Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes

Objective

HYMADE focuses on the development of capsules and engineered colloidal particles for drug delivery combining mesoporous colloids, the Layer by Layer (LbL) technique and virosomes. The capsules and particles have potential applications in cancer and inflammatory diseases such as rheumatoid arthritis and uveitis.
The project is based on the secondments of Early Stage Researchers and Experienced Researchers and networking and training activities between European and non European academic institutions.
HYMADE aims to profit from the combination of hybrid materials to fabricate advanced drug delivery systems with controlled release and targeting efficiency of biological entities. The project also aims to gain understanding of the self assembly process of hybrid materials and the transport properties of the drug delivery systems.The biological fate, drug release, degradation and therapeutical efficiency of the drug delivery systems will be studied in vitro and in vivo with state of the art imaging techniques. To achieve these goals we have gathered an international multidisciplinary team with scientists at the forefront of Material Science, Self assembly, Physics, Chemistry, Biophysics and Imaging from Germany, Austria, France and Spain on the European side and from United States of America, Argentina and Armenia on the non European side.

Field of science

• /social sciences/social and economic geography/transport
• /natural sciences/chemical sciences/polymer science
• /engineering and technology/materials engineering/coating and films
• /natural sciences/biological sciences/biophysics
• /natural sciences/physical sciences/condensed matter physics/soft matter physics
• /medical and health sciences/health sciences/inflammatory diseases
• /medical and health sciences/clinical medicine/cancer
• /natural sciences/biological sciences/biochemistry/biomolecules/lipids
• /natural sciences/biological sciences/biochemistry/biomolecules/nucleic acid

Programme(s)

• H2020-EU.1.3.3. - Stimulating innovation by means of cross-fertilisation of knowledge

Topic(s)

• MSCA-RISE-2014 - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Call for proposal

H2020-MSCA-RISE-2014
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE

Address

Paseo Miramon 182, Parque Tecnologico De San Sebastian Edificio Empresarial C
20009 San Sebastian
Spain

Activity type

Research Organisations

EU contribution

€ 747 000

Participants (3)

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Austria

EU contribution

€ 243 000

Address

Giefinggasse 4
1210 Wien

Activity type

Research Organisations

UNIVERSITAET LEIPZIG

Participation ended

Germany

EU contribution

€ 157 500

Address

Ritterstrasse 26
04109 Leipzig

Activity type

Higher or Secondary Education Establishments

SORBONNE UNIVERSITE

France

EU contribution

€ 72 000

Address

21 Rue De L'ecole De Medecine
75006 Paris

Activity type

Higher or Secondary Education Establishments

Partners (5)

UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN

United States

Address

South Street 3003 1068
46109 1274 Ann Arbor

Activity type

Higher or Secondary Education Establishments

Yerevan State University

Armenia

Address

Alex Manoogian Street 1
0025 Yerevan

Activity type

Higher or Secondary Education Establishments

COMISION NACIONAL DE ENERGIA ATOMICA

Argentina

Address

Avda. Del Libertador 8250
1429 Buenos Aires

Activity type

Research Organisations

CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET)

Argentina

Address

Godoy Cruz 2290
C1425FQB Buenos Aires

Activity type

Research Organisations

UNIVERSIDAD NACIONAL DE GENERAL SAN MARTIN

Argentina

Address

Martin De Irigoyen 3100
1650 San Martin Buenos Aires

Activity type

Higher or Secondary Education Establishments